The first-line therapy in NSCLC is mainly based on the levels of PD-L1 expression in patient biopsies, and in both histological types (adenocarcinoma and squamous cell carcinoma), the first-line treatment includes chemotherapy and immunotherapy combinations. Here, CD274 is linked to squamous cell carcinoma.